DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 065085
The generic ingredient in MUPIROCIN is mupirocin. There are thirteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 065085
Tradename: | MUPIROCIN |
Applicant: | Teva |
Ingredient: | mupirocin |
Patents: | 0 |
Therapeutic Class: | Antibacterials |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 065085
Mechanism of Action | RNA Synthetase Inhibitors |
Medical Subject Heading (MeSH) Categories for 065085
Suppliers and Packaging for NDA: 065085
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MUPIROCIN | mupirocin | OINTMENT;TOPICAL | 065085 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-1010 | N | 0093-1010-42 |
MUPIROCIN | mupirocin | OINTMENT;TOPICAL | 065085 | ANDA | Rebel Distributors Corp | 42254-137 | E | 42254-137-22 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 2% | ||||
Approval Date: | Nov 7, 2003 | TE: | AB | RLD: | No |
Complete Access Available with Subscription